Fernando Lozano Vigario is a scientist at AstraZeneca specializing in the selection of tumor-reactive TCRs for cell therapies at Neogene Therapeutics. They earned a PhD in nanomedicine from Leiden University and a Master's degree in Bio-Pharmaceutical Sciences from the same institution. Fernando has previously interned at the University of Seville and Janssen Vaccines and Prevention, gaining extensive experience in biochemistry, molecular biology, and drug delivery technologies. Their educational background includes a Bachelor's degree in Biochemistry and Biotechnology from the University of Seville.
This person is not in the org chart
This person is not in any teams
This person is not in any offices